
Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is …
Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …

The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …
Sanofi-Aventis has formed a strategic alliance with the Centre for Biodmedical Innovation at the Massachusetts Institute of Technology. The alliance, …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

